Changmao Biochemical Engineering Company Limited (HKG:0954)

Market Cap	174.80M -15.4%
Revenue (ttm)	595.30M -17.0%
Net Income	-82.45M
EPS	-0.16
Shares Out	529.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	180,000
Average Volume	86,600
Open	0.3000
Previous Close	0.3300
Day's Range	0.3000 - 0.3300
52-Week Range	0.2550 - 0.4250
Beta	0.61
RSI	86.82
Earnings Date	Mar 27, 2026

About HKG:0954

Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally. The company offers maleic anhydride, fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L (+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, medical intermediaries, pharmaceutical adjuvant, active pharm...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1992
• Employees: 533
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0954

Financial Performance

In 2024, HKG:0954's revenue was 584.79 million, a decrease of -8.21% compared to the previous year's 637.08 million. Losses were -68.24 million, -20.70% less than in 2023.

Financial numbers in CNY